Los Angeles, CA
Le Meridien Pasadena Arcadia
February 27-28,  2026

Two Days. One Mission. Transforming Precision Cancer Care.

Los Angeles, CA
February 27-28, 2026

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Los Angeles

In the heart of Southern California’s biomedical corridor, this conference—presented in partnership with City of Hopeunites oncologists and pathologists  to explore breakthroughs transforming precision cancer care. Co-chaired by Dr. Stephen Gruber, Vice President of City of Hope National Medical Center, and Dr. Eric F. Glassy, Medical Director of Affiliated Pathologists Medical Group, the program highlights how integrated diagnostic insights and therapy selection are improving outcomes—while fostering meaningful connections across the West Coast. Earn free CE/CME & MOC credits as you engage in thought-provoking discussions that bridge science and clinical practice.

Be part of this integrated, multidisciplinary program that connects diagnostic discovery to therapeutic impact—advancing the future of precision cancer care.

Agenda

EVENT PARTNER

February 27, 2026
8:00 AMRegistration & Check-in
8:50 AMWelcome and Introductions
9:00 AMBreast Cancer
9:30 AMBreast Cancer: Biomarkers & Methodologies Fan Fang, MD, PhD, City of Hope
10:00 AMExhibits/Breakfast
10:30 AMNon-CME Session
11:15 AMExhibits/Break
11:45 AMLung Cancer: Biomarkers and Methodologies Leonidas Arvanitis, MD, City of Hope
12:15 PMLung Cancer Christine Lovly, MD, PhD, FASCO, City of Hope
12:45 PMColorectal Cancer: Biomarkers & Methodologies Stanley Hamilton, MD, FCAP, AGAF, City of Hope
1:15 PMColorectal Cancer Marwan G. Fakih, MD, City of Hope
1:45 PMExhibits/Lunch
2:15 PMNon-CME Session 
2:45 PMExhibits/Break
3:15 PMDigital Pathology Eric F. Glassy, MD, FCAP, City of Hope
3:45 PMLiquid Biopsy
4:15 PMGermline/Somatic Testing Ilana Solomon, MA, ScM, CGC, City of Hope
4:45 PMClosing Remarks
  • Integrate evidence-based advances from both pathology and oncology to enhance biomarker testing, diagnosis, and treatment planning for solid tumors and hematologic malignancies.

  • Apply multidisciplinary insights and new clinical data to improve therapeutic decision-making and patient outcomes across diverse practice settings.

Additional Information Coming Soon

February 28, 2026
8:00 AMCoffee/Exhibits/Registration
8:25 AMWelcome and Introductions
8:30 AMKeynote Stephen Gruber, MD, PhD, MPH, City of Hope National Medical Center
9:00 AMLung Cancer Ravi Salgia, MD, PhD, City of Hope
9:30 AMExhibits/Breakfast
10:00 AMNon-CME Sponsored Session
10:45 AMExhibits/Networking
11:15 AMHemapathology M. James You, MD, PhD, City of Hope
11:45 PMMyeloma
12:15 PMLeukemia Guido Marcucci, MD, City of Hope Comprehensive Cancer Center
12:45 PMExhibits/Lunch
1:15 PMNon-CME Sponsored Session
2:00 PMExhibits/Networking
2:30 PMEarly Detection Kevin McDonnell, MD, PhD, City of Hope
3:00 PMMelanoma Biomarkers Joanne M. Jeter, MD, MS, FASCO, City of Hope
3:30 PMMRD & GTP
4:00 PMClosing Comments

Speakers

THE LOCATION

Le Meridien
130 W. Huntington Drive
Arcadia, CA  91007
Grandstand Ballroom

REGISTRATION

SPONSOR

Interested in sponsoring the event? Email Gary King by using the link below!

Sponsor